Abstract
Hypnosedative-induced complex behaviors have gained increased attention in recent years as a potential complication of benzodiazepines and benzodiazepine-receptor agonist use. Sodium oxybate (SO), the sodium salt of γ-hydroxybutyrate, an inhibitory neurotransmitter, has been associated with dose-dependent rates of somnambulism; however, there is limited information about complex motor behaviors with SO. We describe a patient with narcolepsy-cataplexy who experienced one episode of sleep-driving and at least two sleep-related eating episodes with therapeutic doses of SO.
| Original language | English |
|---|---|
| Pages (from-to) | 310-311 |
| Number of pages | 2 |
| Journal | Journal of Clinical Sleep Medicine |
| Volume | 7 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 15 2011 |
Fingerprint
Keywords
- Narcolepsy
- Parasomnia
- Sleep driving
- Sleep related eating disorder
- Sodium oxybate
ASJC Scopus subject areas
- Clinical Neurology
- Pulmonary and Respiratory Medicine
- Neurology
Cite this
Sodium oxybate-induced sleep driving and sleep-related eating disorder. / Wallace, Douglas; Maze, Tanisha; Shafazand, Shirin.
In: Journal of Clinical Sleep Medicine, Vol. 7, No. 3, 15.06.2011, p. 310-311.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Sodium oxybate-induced sleep driving and sleep-related eating disorder
AU - Wallace, Douglas
AU - Maze, Tanisha
AU - Shafazand, Shirin
PY - 2011/6/15
Y1 - 2011/6/15
N2 - Hypnosedative-induced complex behaviors have gained increased attention in recent years as a potential complication of benzodiazepines and benzodiazepine-receptor agonist use. Sodium oxybate (SO), the sodium salt of γ-hydroxybutyrate, an inhibitory neurotransmitter, has been associated with dose-dependent rates of somnambulism; however, there is limited information about complex motor behaviors with SO. We describe a patient with narcolepsy-cataplexy who experienced one episode of sleep-driving and at least two sleep-related eating episodes with therapeutic doses of SO.
AB - Hypnosedative-induced complex behaviors have gained increased attention in recent years as a potential complication of benzodiazepines and benzodiazepine-receptor agonist use. Sodium oxybate (SO), the sodium salt of γ-hydroxybutyrate, an inhibitory neurotransmitter, has been associated with dose-dependent rates of somnambulism; however, there is limited information about complex motor behaviors with SO. We describe a patient with narcolepsy-cataplexy who experienced one episode of sleep-driving and at least two sleep-related eating episodes with therapeutic doses of SO.
KW - Narcolepsy
KW - Parasomnia
KW - Sleep driving
KW - Sleep related eating disorder
KW - Sodium oxybate
UR - http://www.scopus.com/inward/record.url?scp=79959290344&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959290344&partnerID=8YFLogxK
U2 - 10.5664/JCSM.1082
DO - 10.5664/JCSM.1082
M3 - Article
C2 - 21677903
AN - SCOPUS:79959290344
VL - 7
SP - 310
EP - 311
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
SN - 1550-9389
IS - 3
ER -